Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

CTE and FPHL are different hair loss types with unique causes.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Vitamin C was found to effectively treat prickly heat in children.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

FDG PET/CT scans can change cancer treatment plans for dogs.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.